Nanobiotix announces a virtual event titled "Accelerating the Future of Nanotherapeutics," scheduled to take place at 9:00 AM ET on Thursday, December 19, 2024 (3.54 +0.20)
- Co announces a virtual event titled "Accelerating the Future of Nanotherapeutics," scheduled to take place at 9:00 AM ET / 3:00 PM CET on Thursday, December 19, 2024. Nanobiotix remains focused on advancing its lead program which is proceeding as planned. To enable further growth, Nanobiotix will leverage new nanotherapeutic technologies with the potential to improve treatment outcomes for millions of patients.
- The event will feature a presentation by Laurent Lévy, PhD, Chief Executive Officer of Nanobiotix, and Matthieu Germain, PhD, Head of Curadigm at Nanobiotix. Together, they will outline the future potential of the Curadigm Nanoprimer Platform, an innovative nanotherapeutic technology designed to transform the development of intravenously-administered therapeutics.